Reference is made to the announcement by Duopharma Biotech Berhad (hereinafter referred to as the “Company” or “Duopharma Biotech”) on 26 February 2026 and all the announcements before that in relation to the above matter (hereinafter collectively referred to as the "Previous Announcements"). For consistency purposes, the abbreviations used in this announcement are the same as those previously defined in the Previous Announcements unless otherwise defined herein.

Duopharma Biotech wishes to inform that the High Court at the Case Management today has given the following directions:-

1. Parties to file amended list of witnesses containing brief description of role / evidence to be given, if any, by 5 May 2026;

2. Witness statements to be filed by 19 May 2026; and

3. Trial date on 26 June 2026 is vacated and the replacement trial date is 24 July 2026.

In view of the aforesaid change of trial date, the trial will now be from 9 to 11 June 2026 and 24 July 2026.

The Company will announce further developments on the above matter as and when necessary.

This announcement is dated 5 March 2026.